Andrew F. Leuchter

Andrew F. Leuchter, MD

Primary Location
760 Westwood Plaza
Suite 57-467
Los Angeles, California 90024


Dr. Leuchter is Director of the Transcranial Magnetic Stimulation (TMS) Clinical and Research Program. He is an expert in the use of TMS for the treatment of Major Depressive Disorder (MDD), and its potential uses for other neuropsychiatric disorders, including anxiety disorders, PTSD, auditory hallucinations, and tinnitus.


Medical Board Certifications

Psychiatry, American Board of Psychiatry and Neurology, 1986


UCLA Neuropsychiatric Hospital, 1986


UCLA Neuropsychiatric Hospital, 1984


UCLA School of Medicine, 1981


Baylor College of Medicine (MD Only), MD, 1980

Hospital Affiliations

Ronald Reagan UCLA Medical Center



Link to my PubMed Publications >

  1. Cook IA, Schrader LM, DeGiorgio CM, Miller PR, Maremont ER, Leuchter AF: Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study. Epilepsy & Behavior 2013; 28:221-226
  2. Leuchter AF, Cook IA, Jin Y, Phillips B: The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder. Frontiers in Human Neuroscience 2013; 7(37)1-12
  3. Hunter AM, Korb AS, Cook IA, Leuchter AF: Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? The Journal of Neuropsychiatry and Clinical Neurosciences 2013; 25(2):126-133
  4. Cook IA, Espinoza R, Leuchter AF: Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation). Neurosurgery Clinics of North America 2014; 25:103–116
  5. Leuchter AF, Hunter AM, Tartter M, Cook IA: Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. British Journal of Psychiatry 2014; 205(6):443-9
  6. Leuchter AF, Hunter AM, Krantz DE, Cook IA: Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder. Dialogues in Clinical Neuroscience 2014; 16(4):525-37
  7. McGough JJ, Loo SK, Sturm A, Cowen J, Leuchter AF, Cook IA: An eight-week, open-trial, pilot feasibility study of trigeminal nerve stimulation in youth with attention deficit/hyperactivity disorder. Brain Stimulation 2015; 8(2):299-304
  8. Leuchter AF, Hunter AM, Krantz, DE, Cook IA: Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments. Annals of the New York Academy of Sciences 2015; 1344:78-91
  9. Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, O'Reardon JP, Gilmer WS, Jain R, Burgoyne KS, Phillips B, Manberg PJ, Massaro J, Hunter AM, Lisanby SH, George MS: Efficacy and safety of low-field synchronized transcranial magnetic stimulation (sTMS) for treatment of major depression. Brain Stimulation 2015; 8(4):787-94
  10. Hunter AM, Cook IA, Tartter M, Sharma SK, Disse GD, Leuchter AF: Antidepressant treatment history and drugplacebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology 2015; 232(20):3833-40


  • Invited presenter, XXVII CINP World Congress, CINP (International College of Neuropsychopharmacology), June 6-7, 2010, Hong Kong, SAR
  • Invited presenter, 5th Annual HD Therapeutics Conference, CHDI, Inc., February 9, 2010, Palm Springs, CA
  • Invited presenter, University of Wisconsin School of Medicine and Public Health Psychiatric Update, October 23, 2009, Madison, WI
  • Invited presenter, North American Research Conference on Complementary and Integrative Medicine, National Center for Complementary and Alternative Medicine, Wednesday, May 13, 2009, Washington, DC
  • Invited presenter, "Evidence-based Approaches to Neurophysiologic Testing in Depression," 20th Anniversary Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), September 13, 2008, Frankfurt, Germany
  • Invited presenter, "Using Biomarkers to Change the Way We Treat Depression," Harold Visotsky, M.D. Memorial Lecture at Northwestern University Grand Rounds. April 25, 2007
  • Invited presenter, "Brain Mechanisms in the Placebo Response," Workshop sponsored by the National Institute of Mental Health and the Mind, Brain, Body, and Health Initiative. September 27 – 28, 2004
  • Grant reviewer, Conte Center Study Section, National Institutes of Mental Health, 2009 - 2010
  • Ad hoc grant reviewer, National Center for Complementary and Alternative Medicine, National Institutes of Health, 2003 – 2008
  • Fellow, American Psychiatric Association, 2000
  • Member, Mental Disorders of Aging Review Committee, National Institute of Mental Health, 1998 - 2000
  • Early Career Research Award, American Psychiatric Electrophysiology Association, 1997
  • Outstanding Research Mentor Award, UCLA
  • Award for Outstanding Research, June 1996, UCLA Research Conference on Aging. "NGF in Rats with Nucleus Basalis Lesions: Cholinergic and Quantitative Electroencephalographic Correlates," Holschneider DP, Leuchter AF, Walton NY, Scremin OU, Treiman DM